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Abstract
Introduction: Metabolically obese normal weight (MONW) subjects, despite their normal BMI, present metabolic disturbances charac-
teristic of abdominal obesity. One of the reasons might be subclinical inflammation caused by the fat tissue excess. The aim of this study 
was to assess the association between the accumulation of fat (especially abdominal) and the concentration of selected proinflammatory 
cytokines — interleukins (IL-6, IL-18) and C-reactive protein (CRP). 
Methods and methods: The study population consisted of 342 subjects (218 women, 124 men; age 20–40 years, BMI < 27 kg/m2) recruited 
from a community centre in Wroclaw. The group was divided based on the homeostasis assessment insulin resistance index (HOMA) 
value: 90 MONW subjects with HOMA > 1.69 and 252 subjects as control group. Anthropometric parameters, serum IL-6, IL-18, CRP, 
glucose, insulin concentrations and insulin sensitivity/resistance indexes were evaluated. 
Results: CRP levels were significantly higher (3.26 vs. 1.97, p = 0.03) in MONW women than in the control group. Serum IL-6, IL-18 
levels in males and females did not differ in both groups. IL-6 showed a significant correlation with the abdominal to gynoidal fat tissue 
deposit ratio in women. There were correlations between the CRP and BMI, WHR, waist circumference, total fat, abdominal fat deposit, 
and abdominal to gynoidal fat deposit ratio in both sexes. In women, positive correlations between CRP and HOMA, FIRI and negative 
with QUICKI index were present.
Conclusions: Increased accumulation of abdominal adipose tissue in non-obese, young and healthy subjects is related to increased CRP 
levels. (Endokrynol Pol 2014; 65 (6): 449–455)
Key words: metabolically obese but normal weight subjects; subclinical inflammation; proinflammatory cytokines
Streszczenie
Wstęp: Osoby z zespołem metabolicznej otyłości z prawidłową masa ciała (MONW), mimo prawidłowego wskaźnika masy ciała (BMI), 
są narażone na powikłania typowe dla otyłości. Może to wynikać z subklinicznego stanu zapalnego, wynikającego z nadmiernego gro-
madzenia tkanki tłuszczowej brzusznej. Celem pracy była ocena związku pomiędzy nagromadzeniem tkanki tłuszczowej, szczególnie 
okolicy brzusznej, a stężeniem wybranych cytokin prozapalnych — interleukiny 6, 18 i białka C-reaktywnego (CRP), biorących udział 
w aterogenezie. 
Materiał i metody: Badaniem objęto 342 osoby (218 kobiet, 124 mężczyzn w wieku 20–40 lat, z BMI < 27 kg/m2), mieszkańców Wrocławia. 
Grupę podzielono ze względu na wartość wskaźnika insulinooporności (HOMA): 90 osób — grupa MONW ( HOMA > 1.69), 252 osoby 
— grupa kontrolna. Oceniono parametry antropometryczne, stężenia IL-6, IL-18, CRP, glukozy, insuliny oraz wskaźniki insulinowrażli-
wości i insulinooporności. 
Wyniki: Stężenie CRP było istotnie wyższe w grupie kobiet MONW niż kontrolnej (3,26 vs. 1,97, p = 0,03). Stężenia IL-6 i IL-18 
nie różniły się pomiędzy grupami, zarówno u kobiet, jak i u mężczyzn. Dodatnią korelację zanotowano między stężeniem IL-6 
a wskaźnikiem centralizacji tłuszczu u kobiet. Stwierdzono dodatnią korelację między stężeniem CRP a BMI, wskaźnikiem talia–
biodra, obwodem talii u obu płci. U kobiet istniała także dodatnia korelacja między CRP a wskaźnikami HOMA i FIRI i ujemna ze 
wskaźnikiem QUICKI.
Wnioski: Zwiększone gromadzenie tłuszczu okolicy brzusznej u zdrowych, młodych osób, wiąże się z podwyższonym stężeniem CRP. 
(Endokrynol Pol 2014; 65 (6): 449–455)
Słowa kluczowe: otyłość z prawidłową masą ciała; subkliniczny stan zapalny; cytokiny prozapalne
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of age, BMI < 27 kg/m2. Exclusion criteria were as fol-
lows: presence of known diabetes, hypertension, or 
any other metabolic disorder, oral contraception, other 
drugs. Informed written consent was obtained from all 
participants. The study protocol was approved by the 
ethical committee. The study population was divided 
into subgroups based on the presence of the MONW 
syndrome, which was recognised on the basis of the 
insulin resistance HOMA index value. The cut-off point 
was 1.69, according to the criteria outlined by Conus 
et al. [5]. Two subgroups were established: the MONW 
group, which comprised subjects with HOMA above 
1.69 (n = 90, 58 women and 32 men), and the control 
group, which comprised subjects with HOMA up to 
1.69 (n = 252). 
Body weight and height were measured in the 
morning. The BMI was calculated as body weight in 
kilograms divided by height in square metres (kg/m2). 
Waist circumference was measured at the umbilical 
level, hip circumference was measured at the widest 
part of the hip, and waist-to-hip ratio (WHR) was also 
calculated. Blood samples were drawn after an over-
night fast (12 h) for plasma glucose, insulin. Fasting 
plasma glucose concentrations were measured using 
the glucose oxidase method (Dade Behring Marburg 
GmbH, Germany, Xpand); serum insulin levels by 
a Micro Particle Enzyme Immunoassay (AxSym 
Insulin Kit, Abbott). Dual-energy X-ray absorptiom-
etry was used to measure regional and whole body 
composition (Lunar DPX-plus, Lunar Corporation, 
Madison, WI, USA). Using the ‘total body’ option, 
the body fat content was calculated. The abdominal 
fat was calculated by assigning the percentage of fat 
in the area bounded from above by the upper rim 
coil L2 from the bottom of the lower edge of L4 in 
relation to the total body fat. The hip fat was calcu-
lated by assigning the percentage of fat in the area 
bounded from above by the trochanter major, from 
the bottom of the knee.
Statistical analysis
Variables were described using elements of descrip-
tive statistics and included: minimum and maximum 
value, mean and standard deviation. The distribution of 
variables was examined using the Kołmogorov-Smirnov 
test. Comparisons between groups were performed us-
ing the Mann-Whitney-U test. In order to examine the 
correlation between the analysed indices, Spearman’s 
rank correlation coefficient was calculated. Differences 
at the level below 0.05 were considered statistically 
significant. Results on the borderline of statistical sig-
nificance (0.05 < p < 0.1) were also taken into account. 
Statistical calculations were performed using the com-
puter program Statistica 6.0.
Introduction
Obesity contributes to the development of diabetes, 
atherosclerosis and related cardiovascular diseases 
(CVD) [1, 2]. Studies attempting to explain the exact 
mechanism of CVD, atherosclerosis and its associa-
tion with obesity are now of great importance. Obese 
people are prone to develop specific metabolic 
disorders, but also some non-obese people have 
a tendency to excess accumulation of abdominal fat 
with adverse metabolic consequences [3, 4]. This 
concept was first brought up by Ruderman et al. 
and subjects belonging to this group are defined 
as metabolically obese normal weight (MONW) 
[3,5–8]. They are apparently healthy subjects, al-
though a longitudinal study by Meigs et al. shows 
that the MONW phenotype is associated with a 3- to 
4-fold risk factor-adjusted increased relative risk for 
diabetes or CVD events [9]. There is no universal 
definition or uniform criteria of MONW syndrome 
or specific medical treatment. Insulin resistance/ 
/insulin sensitivity was the criterion in defining 
MONW group in most of the studies [5, 6, 9]. Co-
nus et al. used HOMA over 1.69 as a cut-off value, 
based on their earlier studies using a euglycaemic-
hyperinsulinaemic clamp [5]. 
Despite normal BMI, MONW subjects present 
increased adiposity, particularly in abdominal and vis-
ceral areas. This phenomenon may be associated with 
increased levels of proinflammatory cytokines. Adipose 
tissue is a very important source of increased secretion 
of proinflammatory cytokines [10–14]. Many publica-
tions on this subject concern obese people, whereas 
only a handful of studies have been conducted among 
MONW subjects. There have been few studies concern-
ing the correlation between the amount of abdominal 
fat in MONW subjects and the level of inflammation 
markers, which are known to play a key role in the 
process of atherosclerotic plaque formation [8, 15, 16]. 
Recognition of such correlations in MONW subjects 
could help in the quick identification of affected people 
and allow early intervention. 
Therefore, the aim of this study was to evaluate the 
association between abdominal adipose tissue deposit 
in non-obese males and females and blood level of 
selected proinflammatory cytokines — CRP, IL-6 and 
IL-18. 
Material and methods
The study population consisted of 342 subjects — 218 
women and 124 men. Subjects were recruited from 
a community centre in Wroclaw and were included in 
the study if they met the following criteria: 20–40 years 
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Results 
Antropometric parameters in study population 
The analysis performed independently of sex showed 
that all study parameters (body weight, BMI, waist and 
hip circumference, WHR) except for age were higher in 
the MONW group (Table I). Similar data was observed in 
groups of women and men separately (Tables II and III). 
Adipose tissue volume in study population 
The analysis of the study population showed that the 
total adipose tissue volume expressed in grams was 
significantly higher in MONW subjects than in normal 
subjects (Table I). MONW individuals were characterised 
by significantly higher accumulation of abdominal fat, 
both in grams and percentages, and lower accumula-
tion of gynoid adipose tissue expressed as percentages, 
compared to normal controls. The value of abdominal/ 
/gynoidal deposit quotient was also significantly higher 
in MONW subjects. In the group of women, MONW 
subjects and controls revealed significant differences in the 
total adipose tissue volume and abdominal fat (Table II). 
Also, MONW subjects were characterised by significantly 
higher volume of adipose tissue and abdominal deposit. 
In the group of men, significantly higher adipose tissue 
mass in MONW subjects compared to normal subjects 
was observed (Table III). The difference in the abdominal 
and gynoidal deposit quotient in these groups was on 
the borderline of statistical significance and was higher 
in MONW subjects. 
Carbohydrate metabolism parameters in study 
population
MONW subjects had significantly higher fasting glu-
cose and insulin levels and significantly higher HOMA 
index. This is predictable, since the index was the cri-
terion of division into the subgroups. Also, the other 
insulin resistance index (FIRI) was significantly higher, 
whereas the insulin sensitivity index (QUICKI) was 
significantly lower. These differences were observed 
both for the whole population and after division with 
regard to sex (Tables I–III). 
Serum inflammatory cytokines concentrations  
in study population 
The CRP concentration was higher in MONW women 
and men compared to control groups, but the difference 
was statistically significant in women only (Table IV). 
IL-18 and IL-6 levels did not reveal significant differ-
ences between both groups. 
Table I. Comparison of selected anthropomorphic and carbohydrate parameters in the MONW group and control subjects
Tabela I. Porównanie wybranych parametrów antropometrycznych i wskaźników gospodarki węglowodanowej w grupie 
MONW i kontrolnej
Non-obese normal (n = 252) U Mann-Whitney test 
p-value
MONW (n = 90)
Means SD Means SD
Age (years) 30.85 5.55 0.073831 29.67 5.66
Body weight [kg] 63.75 11.67 < 0.001 69.95 11.40
Height [cm] 170.35 9.45 < 0.001 173.67 8.77
BMI [kg/m2] 21.82 2.47 < 0.001 23.06 2.35
Waist [cm] 75.89 9.57 < 0.001 82.00 9.57
Hip [cm] 98.38 5.67 < 0.005 100.47 5.96
WHR 0.77 0.07 < 0.001 0.81 0.07
Total fat [g] 15,729.29 4,424.00 < 0.05 17,052.12 6,199.77
Total fat (%) 25.49 6.57 0.080 24.47 7.33
Abdominal deposit [g] 1,139.91 543.25 < 0.001 1,402.58 631.38
Abdominal deposit (%) 21.59 6.78 < 0.050 23.31 7.58
Gynoidal deposit [g] 4,819.74 1,449.42 0.226 4,583.86 1,551.04
Gynoidal deposit (%) 30.95 8.66 < 0.01 27.45 9.25
Abdominal/gynoidal deposit 0.24 0.11 < 0.01 0.33 0,.14
Glucose [mg/dL] 79..21 6.99 < 0.001 84.61 8.21
Insulin 5.99 2.71 < 0.01 8.11 4.21
HOMA 1.07 0.43 < 0.01 2.33 0.77
FIRI 0.95 0.35 < 0.001 1.49 0.87
QUICKI 0.40 0.05 < 0.01 0.31 0.03
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Table II. Comparison of selected anthropomorphic and carbohydrate parameters in the MONW and control women 
Tabela II. Porównanie wybranych parametrów antropometrycznych i wskaźników gospodarki węglowodanowej w grupie 
MONW i kontrolnej kobiet
Non-obese normal (n = 160) U Mann-Whitney test 
p-value
MONW (n = 58)
Means SD Means SD
Age (years) 29.35 6.55 0.06754 29.67 5.66
Body weight [kg] 59.75 8.65 < 0.001 62.85 7.40
Height [cm] 167.22 8.22 < 0.05 169.77 6.77
BMI [kg/m2] 21.55 1.99 < 0.001 23.00 1.35
Waist [cm] 74.88 7.10 < 0.001 80.01 8.87
Hip [cm] 97.13 4.57 < 0.005 99.48 5.01
WHR 0.75 0.05 < 0.001 0.85 0.05
Total fat [g] 16,215.18 4,321.00 < 0.01 17,022.66 6,087.65
Total fat (%) 27.11 6.22 0.16 27.18 6.01
Abdominal deposit [g] 1,098.21 499.34 < 0.001 1,322.44 593.18
Abdominal deposit (%) 20.99 5.77 < 0.001 23.99 6.55
Gynoidal deposit [g] 5,119.99 1,529.44 0.233 5,212.66 1,531.11
Gynoidal deposit (%) 34.98 8.00 0.061 28.33 8.15
Abdominal/gynoidal deposit 0.22 0.15 < 0.001 0.35 0.12
Glucose [mg/dL] 76.22 5.19 < 0.001 82.61 7.99
Insulin 5.76 2.22 < 0.01 7.99 3.59
HOMA 1.03 0.39 < 0.01 2.30 0.69
FIRI 0.93 0.34 < 0.001 1.39 0.77
QUICKI 0.45 0.03 < 0.01 0.30 0.03
Table III. Comparison of selected anthropomorphic and carbohydrate parameters in the MONW and control men 
Tabela III. Porównanie wybranych parametrów antropometrycznych i wskaźników gospodarki węglowodanowej w grupie 
MONW i kontrolnej mężczyzn
Non-obese normal (n = 92) U Mann-Whitney test 
p-value
MONW (n = 32)
Means SD Means SD
Body weight [kg] 70.75 9.22 < 0.010 72.00 7.40
Height [cm] 176.35 8.22 0.081 175.67 7.99
BMI [kg/m2] 22.89 2.47 < 0.001 25.18 2.66
Waist [cm] 86.99 9.57 < 0.001 82.00 9.57
Hip [cm] 98.38 6.66 < 0.010 101.44 5.99
WHR 0.86 0.06 0.071 0.89 0.06
Total fat [g] 14,221.15 4,111.00 < 0.05 16,052.12 5,223.27
Total fat (%) 18.01 5.25 0.090 19.97 6.99
Abdominal deposit [g] 1,234.51 443.25 0.057 1,501.58 521.15
Abdominal deposit (%) 17.99 5.28 0.061 20.11 6.11
Gynoidal deposit [g] 3,205.56 1,321.11 0.146 3,583.86 1,523.33
Gynoidal deposit (%) 19.22 8.23 0.066 25.33 7.21
Abdominal/gynoidal deposit 0.30 0.16 0.060 0.34 0.12
Glucose [mg/dL] 87.33 7.21 < 0.010 91.66 9.07
Insulin 6.01 2.99 < 0.010 9.01 3.21
HOMA 1.10 0.29 < 0.001 2.48 0.61
FIRI 0.99 0.31 < 0.001 2.28 0.81
QUICKI 0.40 0.43 < 0.010 0.29 0.03
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Correlations between inflammatory cytokines and:
— anthropometric parameters 
In the group of women, statistically significant positive 
correlations were observed between CRP level and body 
mass, BMI, waist and hip circumference and WHR. 
IL-18 level was positively correlated with body mass, 
waist, WHR (Table V). CRP level in men, similarly to 
women, was positively correlated to BMI, waist circumfer-
ence and WHR. IL-18 in men was significantly correlated 
only with hip circumference (Table VI). IL-6 level did not 
reveal statistically significant correlations with any of the 
analysed anthropometric parameters (Tables V and VI).
— carbohydrate metabolism parameters 
The CRP level in the group of women revealed statistically 
significant positive correlations between insulin levels, 
HOMA and FIRI indices, and a negative correlation with 
the QUICKI index. No significant correlations between IL-
18 levels and all study parameters of carbohydrate metabo-
lism were observed. IL-6 levels were positively correlated 
with glucose level, HOMA and FIRI index in women only 
(Table V). In the group of men, no correlation was observed 
between the level of all studied inflammation markers and 
carbohydrate metabolism parameters (Table VI). 
— adipose tissue content 
The total adipose tissue volume, as well as the volume 
of abdominal and gynoidal deposit and the abdominal/ 
/gynoidal deposit ratio in the group of women, showed 
significant correlations with CRP level. IL-6 was posi-
tively correlated only with the abdominal/gynoidal 
deposit ratio (Table VII). In the group of men, the total 
fat volume and fat deposited in abdominal region, as 
well as the centralisation index, showed significant 
positive correlations only with CRP level (Table VIII). 
Discussion 
In a review of MONW individuals, Ruderman et al. noted 
that MONW subjects have increased adipose tissue mass 
compared to normoinsulinaemic individuals of similar 
height and weight [4]. Elevated abdominal visceral fat 
can be a risk factor for the development of metabolic 
abnormalities also in people who are regarded as non-
obese, because it contributes to insulin resistance [7]. In 
a cross-sectional survey consisting of more than 7,000 
subjects in U.S., the prevalence of the metabolic syndrome 
(due to ATPIII criteria) increased from 0.9–3.0% at BMI 
18.5–20.9 kg/m2 to 9.6–22.5% at BMI 25.0–26.9 kg/m2 [17]. 
In a previous study conducted in Poland, using a definition 
based on HOMA value over 1.69, we found that MONW 
syndrome frequency was 21.76% in women and 31.42% in 
men with BMI below 25 [18]. In our present study, based 
on a Wrocław population, MONW subjects were charac-
terised by BMI up to 27 and insulin resistance measured 
by the HOMA value was also the basic criterion.
Table IV. Serum concentrations of interleukin-18 (IL-18), interleukin-6 (IL-6), C-reactive protein (CRP) in MONW women 
and men and control groups 
Tabela IV. Stężenia interleukiny 18 (IL-18), interleukiny 6 (IL-6), białka C-reaktywnego (CRP) w grupach MONW i kontrolnych 
u kobiet i mężczyzn
Women Men
MONW (n = 35) Control (n = 183) U Mann-Whitney 
test
       MONW  
       (n = 55)
Control (n = 69) U Mann-Whitney  
test
Means SD Means SD p-value Means SD Means SD p-value
IL-6 16.92 6.33 17.04 5.78 0.94 15.99 4.89 15.18 4.71 0.52
IL-18 240.48 65.05 248.01 84.29 0.72 276.52 75.44 291.83 98.99 0.51
CRP 3.26 3.67 1.97 2.38 0.03 2.43 2.02 2.14 2.12 0.11
Table V. The correlations between serum concentrations of IL-6, IL-18, CRP and anthropometric and serum glucose, insulin 
concentrations and insulin resistance and insulin sensitivity indices in women
Tabela V. Korelacje pomiędzy stężeniami IL-6, IL-18, CRP i parametrami antropometrycznymi, stężeniem glukozy, insuliny, 
insulinoopornością oraz insulinowrażliwością u kobiet
Body weight 
[kg]
BMI  
[kg/m2]
Waist  
[cm]
Hip  
[cm]
WHR Fasting 
glucose [mg]
Insulin  
[µIU/mL]
HOMA QUICKI FIRI
IL-6 NS NS NS NS NS 0.27 NS 0.39 NS 0.39
IL-18 0.15 NS 0.17 NS 0.15 NS NS NS NS NS
CRP 0.25 0.27 0.36 0.27 0.17 NS 0.23 0.23 –0.19 0.23
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MONW individuals in our study presented a higher 
accumulation of abdominal fat, both in grams and per-
centages, and a lower accumulation of gynoid adipose 
tissue expressed as percentages, compared to normal 
controls. This accumulation of central fat in normal 
weight subjects promotes the production of proinflam-
matory cytokines. Hyun et al. have noted that MONW 
women with BMI < 25 kg/m2 but a high volume of 
visceral adipose tissue (VFA > 100 cm3) showed higher 
concentrations of tumour necrosis factor α (TNF-α), 
IL-6, leptin and CRP but a lower plasma concentration 
of adiponectin compared to normal controls [8].
Increased adipose tissue volume, especially that 
located in the abdominal region, is known to be related 
to increased CRP in blood [19]. In their study, Bo et al. 
observed a significant correlation between the total 
content of adipose tissue and the CRP level in healthy 
subjects [20]. Our results agree with those findings — 
we have found that there are significant positive cor-
relations between the total adipose tissue volume and 
the CRP level in both men and women. 
The volume of abdominal fat deposits and abdomi-
nal/gynoidal deposits ratio in both groups were also 
positively correlated with the level of this cytokine. As 
a natural consequence, we found that CRP was higher 
in MONW women than in controls, and in men we 
observed the same trend. However, it did not reach 
statistical significance. The results show that CRP level 
is correlated with insulin resistance, especially in the 
group of non-obese women. This has important clinical 
implications because in large prospective studies among 
postmenopausal women, hs-CRP was a strong univariate 
predictor of the risk of cardiovascular events: the relative 
risk of events for women in the highest quartile com-
pared to the lowest quartile for this marker was 4.4 [14]. 
So, elevated serum CRP in apparently healthy sub-
jects may be a predictor for accelerated development 
of atherosclerosis and cardiovascular complications, 
because it is associated with increased central fat ac-
cumulation and insulin resistance.
In our study, IL-18 presented no correlation with the 
adipose tissue mass and distribution but only with waist 
Table VI. The correlations between IL-6, IL-18, CRP levels and anthropometric parameters, glucose, insulin levels, insulin 
resistance and insulin sensitivity in men
Tabela VI. Korelacje pomiędzy stężeniami IL-6, IL-18, CRP i parametrami antropometrycznymi, stężeniem glukozy, insuliny, 
insulinoopornością oraz insulinowrażliwością u mężczyzn
Body weight 
[kg]
BMI  
[kg/m2]
Waist  
[cm]
Hip  
[cm]
WHR Fasting 
glucose [mg]
Insulin  
[µIU/mL]
HOMA QUICKI FIRI
IL-6 NS NS NS NS NS NS NS NS NS NS
IL-18 NS NS NS 0.20 NS NS NS NS NS NS
CRP NS 0.17 0.21 NS 0.18 NS NS NS NS NS
Table VII. The correlations between adipose tissue and its abdominal and gynoidal deposit and cytokine concentrations in 
the group of women
Tabela VII. Korelacje pomiędzy ilością tkanki tłuszczowej trzewnej i gynoidalnej ze stężeniem cytokin w grupie kobiet
Total fat [g] Total fat (%) Abdominal 
deposit [g]
Abdominal 
deposit (%)
Gynoidal deposit 
[g]
Gynoidal deposit 
(%)
Abdominal/
gynoidal deposit
IL-6 NS NS NS NS NS NS 0.16
IL-18 NS NS NS NS NS NS NS
CRP 0.29 0.26 0.29 0.27 0.22 0.19 0.19
Table VIII. The correlations between adipose tissue and its abdominal and gynoidal deposit and cytokine concentrations in 
the group of men
Tabela VIII. Korelacje pomiędzy ilością tkanki tłuszczowej trzewnej i gynoidalnej ze stężeniem cytokin w grupie mężczyzn
Total fat [g] Total fat (%) Abdominal 
deposit [g]
Abdominal 
deposit (%)
Gynoidal deposit 
[g]
Gynoidal deposit 
(%)
Abdominal/
gynoidal deposit
IL-6 –0.18 –0.18 –0.18 –0.18 –0.14 –0.16 –0.12
IL-18 0.18 0.09 0.18 0.15 0.02 –0.03 0,15
CRP 0.36 0.35 0.44 0.34 0.08 0.18 0.35
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circumference and WHR index in women. The data 
presented in available publications remains unclear. The 
Dallas Heart Study revealed the correlation of IL-18 with 
BMI, total fat volume, visceral fat assessed with waist 
circumference and WHR index, as well as lean body mass 
[21]. There are also studies showing no differences in IL-18 
levels between obese and normal subjects. In those studies, 
there was no correlation between the IL-18 level and BMI, 
adipose tissue content and distribution [22]. The authors 
of these studies claim that the lack of correlation between 
IL-18 level and body mass, especially fat content, under-
mines the importance of adipose tissue as the main source 
of this cytokine in serum. Other studies contradict these 
results, e.g. Skurk et al. evaluated expression of mRNA 
for IL-18 and secretion of this cytokine by adipocytes 
and preadipocytes from adipose tissue collected during 
surgical procedures. They recorded higher IL-18 levels in 
obese subjects [23]. The role of IL-18 in the development 
of metabolic abnormalities seems to be significant and 
requires further research; its elevated concentration has 
been suggested to be a risk factor for metabolic syndrome 
independently of obesity [11]. Moreover, IL-18 is highly 
expressed in atherosclerotic plaques, probably promoting 
its instability [24]. That could increase cardiovascular mor-
tality in MONW subjects observed in recent studies [25]. 
The results of the present study have shown a cor-
relation between IL-6 level and abdominal/gynoidal 
deposit ratio in women. One third of IL-6 circulating 
in vessels comes from adipose tissue, and this amount 
is even greater in obese subjects. Increased IL-6 levels 
are related to insulin resistance and constitute a risk 
factor for the development of type 2 diabetes mellitus 
and cardiovascular diseases [26]. Some studies have 
shown elevated IL-6 concentrations in individuals with 
excessive fat mass [8, 15], and the positive correlations 
with the abdominal/gynoidal deposit ratio in women 
in our study might also suggest this association. 
Increased IL-6 levels may be considered an early and 
sensitive marker of inflammation. Its determination, 
however, is rarely useful due to high circadian fluctua-
tions of serum level of this cytokine, which means that it 
is less important as a marker of inflammation than CRP 
[27]. The highest IL-6 release from the subcutaneous 
adipose tissue was recorded in evening hours. Perhaps 
the above-mentioned circadian changes in IL-6 level 
underlie the fact that the present study has not revealed 
a clear correlation between adipose tissue volume and 
IL-6 level or differences of IL-6 concentration between 
MONW and control group. 
Conclusions
The accumulation of abdominal fat in young healthy 
and non-obese subjects is associated with increased 
synthesis of CRP. An assessment of abnormal serum 
CRP level may be helpful in the early identification of 
subjects with an increased risk of atherosclerosis. Then 
it would be possible to undertake preventive actions. 
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